Piao L, Zhao G, Zhu E, Inoue A, Shibata R, Lei Y, Hu L, Yu C, Yang G, Wu H
A recent randomised clinical trial demonstrated that exenatide, a GLP-1 receptor agonist, significantly reduced ICP in patients with active IIH from as early as 2.5 h, with effects seen at 24 h and 3 months with continued dosing
It is suitable for adult patients with type 2 diabetes whose blood sugar is still poorly controlled by metformin and/or sulfonylurea drugs on the basis of diet control and exercise
The role of area postrema neurons expressing H-channels in the induction mechanism of nausea and vomiting
Its clinically backed, convenient, and crafted for absorption, making it one of the best glutathione tablets in India